Although our and prior studies reported that HER2 overexpression led to a poor outcome; in contrast, others reported that HER2 expression level was not related to prognosis in resectable GC (Kataoka et al. 2013; Kim et al. 2019; Shen et al. 2016). This evidence concerns the gene ERBB2 and gastric cancer.